Please assess the completion status of the following clinical trial:

Trial Title: Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Phakic study eye~* IOP ≥ 21 mmHg and ≤ 40 mmHg at screening exam (OHT requires second screening)~Exclusion Criteria:~* Aphakic or pseudophakic eyes (AC-IOLs or PC-IOLs)~* Previous usage of topical prostaglandin analogues or prior medical therapy for glaucoma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- iStent (Type: ACTIVE_COMPARATOR): Implantation of two iStent devices
- Drug (Type: ACTIVE_COMPARATOR): Travoprost drops

Based on this trial design, predict the completion outcome and termination type (if applicable).